Examining Colorectal Cancer Screening Preferences
Stool-based tests were favored over colonoscopy for colorectal cancer screening, according to research published in the AACR journal Cancer Prevention...
Stool-based tests were favored over colonoscopy for colorectal cancer screening, according to research published in the AACR journal Cancer Prevention...
THE FDA APPROVED THE FIRST ADJUVANT IMMUNOTHERAPY FOR EARLY LUNG CANCER The U.S. Food and Drug Administration (FDA) granted...
Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
Community level programs were effective and can be expanded to help reduce colorectal cancer disparities, according to a study...
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
The FDA approved the use of an immunotherapeutic in combination with chemotherapy to treat certain patients with triple-negative breast...
Protein signatures in the blood could help guide physicians in choosing among different immunotherapy drugs.
The FDA has approved the molecularly targeted therapeutic olaparib for treating patients who have HER2-negative breast cancer and who...
Improvements in medical care have reduced the rate of relapse in acute myeloid leukemia after transplants, helped people live...
Being overweight or obese increases the risk for certain cancers and complications from treatment. Each of us knows that...
Due to the high cost of care and cost-sharing, many of the more than 16.9 million survivors in the...
A recent study revealed large variations in colorectal cancer screening rates among states and counties. Colorectal cancer is the...
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
The FDA has approved an immunotherapeutic for certain patients with these cancers who had their cancer completely resected and...
The U.S. Food and Drug Administration approval provides a new option for patients whose disease has worsened after treatment...
The newly approved therapeutic is for treating women whose cancers test positive for BRCA1 and BRCA2 mutations with a...
The FDA has expanded the use of the immunotherapeutic pembrolizumab to treat certain patients with cervical cancer. The U.S....
The approval provides the first new treatment option in more than 30 years for patients with the most common...
Improving the rates of cervical cancer screening and HPV vaccination could have significant benefits on this form of cancer....
Study suggests working within religious framework may help ease cultural barriers to cancer screening procedure. Muslim women in America...
The researchers are interested in understanding why some lesions turn into pancreatic cancer to better identify those with a...
Despite concerns that reducing nicotine levels in cigarettes could have unintended effects on smoking behavior, findings from two recent...
Study: Thyroid cancer survivors – especially those diagnosed before age 40 – had elevated risk for several aging-related diseases....
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
Physicians consider which patients are ideal for immunotherapy drug combinations.
Finding the latest discoveries in breast cancer care together. More than 7,000 breast cancer researchers, survivors, advocates, and others...
The U.S. Food and Drug Administration approval expands the use of the immunotherapeutic pembrolizumab to certain patients with the...
The FDA-approved therapeutic is the first to target the T790M EGFR mutation that frequently causes resistance to other EGFR-targeted...
Patients given waivers to participate in A trial had outcomes the same or slightly better than people who met...
A new study found that a decrease in a specific population of circulating tumor cells over the first two...